Trial site
Fondazione PTV - POLICLINICO TOR VERGATA
- 10running trials
- 3closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation2 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 trials
- Colorectal cancer2 trials
- Acute myeloid leukaemia1 trial
- Atopic dermatitis (eczema)1 trial
- Autism1 trial
- Idiopathic pulmonary fibrosis1 trial
- Lung cancer1 trial
- Multiple myeloma1 trial
- Multiple sclerosis1 trial
- Myasthenia gravis1 trial
- Phase
- Phase 25 trials
- Phase 32 trials
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Completed3 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Boston Scientific Corporation2 trials
- Immunovant Sciences GmbH2 trials
- ACADIA Pharmaceuticals Inc.1 trial
- argenx1 trial
- Fondazione Ricerca Traslazionale1 trial
- and 6 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
Active, not recruiting
Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Active, not recruiting
Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT)
Not yet recruiting
Completed
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Atrial fibrillation1 recruiting
- Colorectal cancer1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Multiple myeloma1 recruiting
- Myasthenia gravis1 recruiting
Closed trials
Completed
A Phase 2b Study to Assess the Safety and tolerability of Batoclimab in Patients with CIDP
Completed
Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP.
Completed
Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder
Site data: ClinicalTrials.govUpdated 12 Nov 2026